
The authors describe a novel approach for assessing method robustness. This article contains online-bonus material and was copublished with Pharmaceutical Technology Europe.
George Okafo is a manager in Scinovo, Preclinical Development at GlaxoSmithKline (UK).

The authors describe a novel approach for assessing method robustness. This article contains online-bonus material and was copublished with Pharmaceutical Technology Europe.

Published: April 2nd 2010 | Updated: